Table 2

FAS expression and preoperative parameters
FAS expression
Parameters Patients Low High P value
Clinical T stage
 cT1c 71 31 40 0.0381
 cT2-cT3 31 7 24
PSA (ng/ml)
 ≤ 10 60 24 36 0.4919
 10 < 42 14 28
Needle biopsy Gleason score
 ≤ 6 31 18 13 0.0044
 7 ≤ 71 20 51
Positive core rate (%)
 ≤ 40 72 33 39 0.0038
 40 < 30 5 25
D’Amico risk classification
 Low and Intermediate risk 67 28 39 0.1853
 High risk 35 10 25

Hamada et al.

Hamada et al. BMC Clinical Pathology 2014 14:3   doi:10.1186/1472-6890-14-3

Open Data